Index RUT P/E - EPS (ttm) -0.31 Insider Own 1.10% Shs Outstand 50.77M Perf Week 0.88%
Market Cap 3.43B Forward P/E 85.84 EPS next Y 0.78 Insider Trans -15.94% Shs Float 50.46M Perf Month -0.68%
Income -15.95M PEG - EPS next Q 0.14 Inst Own 98.40% Short Float 8.00% Perf Quarter -0.55%
Sales 387.14M P/S 8.87 EPS this Y 330.56% Inst Trans 3.19% Short Ratio 4.72 Perf Half Y 29.96%
Book/sh 12.29 P/B 5.47 EPS next Y 183.28% ROA -2.31% Short Interest 4.04M Perf Year 29.86%
Cash/sh 6.52 P/C 10.31 EPS next 5Y - ROE -2.65% 52W Range 47.59 - 69.68 Perf YTD 8.12%
Dividend Est. - P/FCF - EPS past 5Y 36.15% ROI -2.43% 52W High -3.44% Beta 0.91
Dividend TTM - Quick Ratio 8.04 Sales past 5Y 541.82% Gross Margin 72.90% 52W Low 41.37% ATR (14) 0.48
Dividend Ex-Date - Current Ratio 9.96 EPS Y/Y TTM 68.47% Oper. Margin -1.93% RSI (14) 49.74 Volatility 0.97% 0.57%
Employees 797 Debt/Eq 0.05 Sales Y/Y TTM 30.82% Profit Margin -4.12% Recom 2.78 Target Price 71.57
Option/Short Yes / Yes LT Debt/Eq 0.05 EPS Q/Q -97.11% Payout - Rel Volume 0.40 Prev Close 67.11
Sales Surprise 1.81% EPS Surprise -521.93% Sales Q/Q 29.38% Earnings Apr 30 AMC Avg Volume 856.18K Price 67.28
SMA20 0.20% SMA50 -0.77% SMA200 9.84% Trades
Volume 345,676 Change 0.25%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-09-24 Downgrade Wolfe Research
Outperform → Peer Perform
Jul-19-23 Initiated Robert W. Baird
Outperform
$69
Jul-13-23 Initiated KeyBanc Capital Markets
Overweight
$70
May-23-23 Initiated CL King
Buy
$75
Apr-14-23 Initiated Mizuho
Buy
$75
Mar-24-23 Upgrade Needham
Hold → Buy
$71
Oct-21-22 Initiated RBC Capital Mkts
Outperform
$85
Oct-12-22 Initiated Jefferies
Hold
$75
Oct-10-22 Downgrade Needham
Buy → Hold
Apr-06-22 Initiated Wolfe Research
Outperform
$69
Mar-02-22 Resumed BofA Securities
Buy
$70
Jul-12-21 Initiated Barclays
Overweight
$74
Jun-28-21 Reiterated Needham
Buy
$72 → $78
Nov-05-20 Reiterated Needham
Buy
$57 → $62
Oct-23-20 Initiated Guggenheim
Buy
$77
Sep-02-20 Initiated Robert W. Baird
Outperform
$52
Aug-07-20 Reiterated Needham
Buy
$48 → $57
Jan-08-20 Initiated SunTrust
Buy
$38
Nov-01-19 Initiated Piper Jaffray
Overweight
$39
Oct-21-19 Initiated Barclays
Overweight
$43
Show Previous Ratings
Apr-30-24 09:56PM
04:08PM
(Associated Press Finance)
04:01PM
Apr-25-24 10:25AM
Apr-24-24 06:30AM
12:00PM
Loading…
Mar-29-24 12:00PM
Mar-22-24 04:01PM
Mar-21-24 04:54PM
Mar-15-24 08:53AM
Mar-14-24 06:00AM
Feb-29-24 04:01PM
Feb-28-24 07:01PM
05:40PM
04:41PM
(Associated Press Finance)
04:01PM
09:09PM
Loading…
Feb-02-24 09:09PM
Jan-31-24 06:30AM
Jan-29-24 11:02PM
Jan-25-24 08:07AM
Jan-23-24 02:45PM
Jan-10-24 03:07PM
Jan-08-24 07:38PM
11:28AM
07:58AM
(The Wall Street Journal)
07:00AM
07:00AM
07:00AM
Dec-27-23 04:01PM
Nov-20-23 09:55AM
Nov-06-23 12:00PM
06:00AM
Loading…
Nov-01-23 06:00AM
Oct-31-23 09:27AM
Oct-30-23 05:55PM
05:40PM
04:28PM
(Associated Press Finance)
04:01PM
Oct-26-23 10:02AM
Oct-23-23 10:00AM
Oct-16-23 10:23AM
Oct-14-23 01:15PM
Oct-11-23 11:42AM
Oct-02-23 06:00AM
Sep-22-23 11:47AM
Sep-11-23 11:47AM
Aug-25-23 06:00AM
Aug-21-23 06:00AM
Jul-28-23 12:46PM
Jul-27-23 05:25PM
04:18PM
04:01PM
Jun-29-23 06:00AM
May-31-23 10:27AM
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:07PM
04:01PM
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Sep-26-22 09:40AM
Sep-12-22 09:15AM
Sep-08-22 06:00AM
Sep-07-22 09:40AM
Aug-22-22 09:40AM
Aug-18-22 06:00AM
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Noblett Karen Chief Medical Officer Jan 31 '24 Option Exercise 0.00 27,500 0 45,716 Feb 02 05:59 PM Sama Rinda Chief Operating Officer Jan 31 '24 Option Exercise 0.00 28,000 0 83,854 Feb 02 06:00 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Option Exercise 0.00 28,000 0 93,302 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Option Exercise 0.00 25,500 0 60,065 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Option Exercise 0.00 6,167 0 46,812 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Option Exercise 0.00 63,400 0 223,996 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Sale 67.74 35,161 2,381,662 188,835 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Sale 67.74 16,615 1,125,432 43,450 Feb 02 05:59 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Sale 67.74 15,899 1,076,933 77,403 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 31 '24 Sale 67.74 11,288 764,603 34,428 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Sale 67.74 3,489 236,331 43,323 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 08 '24 Sale 69.00 15,999 1,103,961 18,216 Jan 10 08:00 PM Noblett Karen Chief Medical Officer Dec 28 '23 Sale 63.28 7,051 446,177 34,215 Dec 28 07:17 PM Noblett Karen Chief Medical Officer Dec 26 '23 Sale 63.00 949 59,787 41,266 Dec 28 07:17 PM Dearen Danny L. President & CFO Sep 29 '23 Option Exercise 0.00 11,250 0 31,452 Oct 03 07:37 PM Dearen Danny L. President & CFO Sep 29 '23 Sale 56.87 7,675 436,490 23,777 Oct 03 07:37 PM Ford Alfred J Jr Chief Commercial Officer Aug 15 '23 Sale 62.34 14,769 920,671 34,565 Aug 17 07:47 PM Ford Alfred J Jr Chief Commercial Officer Jul 28 '23 Sale 62.01 1,500 93,021 49,334 Aug 01 08:01 PM Dearen Danny L. President & CFO May 26 '23 Sale 49.46 7,999 395,646 9,202 May 31 08:01 PM
Index RUT P/E 25.59 EPS (ttm) 3.84 Insider Own 2.08% Shs Outstand 16.23M Perf Week 3.87%
Market Cap 1.61B Forward P/E 18.39 EPS next Y 5.34 Insider Trans -10.22% Shs Float 16.03M Perf Month -3.88%
Income 62.52M PEG 1.71 EPS next Q 1.11 Inst Own 94.18% Short Float 2.20% Perf Quarter 10.49%
Sales 1.06B P/S 1.52 EPS this Y 6.17% Inst Trans 2.50% Short Ratio 2.58 Perf Half Y 21.49%
Book/sh 43.55 P/B 2.25 EPS next Y 9.82% ROA 6.37% Short Interest 0.35M Perf Year 17.59%
Cash/sh 3.96 P/C 24.81 EPS next 5Y 15.00% ROE 9.33% 52W Range 77.30 - 104.61 Perf YTD 5.76%
Dividend Est. - P/FCF 15.64 EPS past 5Y 23.63% ROI 7.18% 52W High -6.13% Beta 0.99
Dividend TTM - Quick Ratio 1.38 Sales past 5Y 15.56% Gross Margin 31.09% 52W Low 27.04% ATR (14) 3.07
Dividend Ex-Date - Current Ratio 1.38 EPS Y/Y TTM 34.76% Oper. Margin 9.21% RSI (14) 52.89 Volatility 3.02% 3.21%
Employees 34846 Debt/Eq 0.25 Sales Y/Y TTM 11.31% Profit Margin 5.91% Recom 1.56 Target Price 109.12
Option/Short Yes / Yes LT Debt/Eq 0.23 EPS Q/Q 32.22% Payout 0.00% Rel Volume 0.86 Prev Close 98.41
Sales Surprise 0.69% EPS Surprise 12.60% Sales Q/Q 11.86% Earnings May 06 AMC Avg Volume 136.55K Price 98.20
SMA20 1.34% SMA50 0.39% SMA200 8.14% Trades
Volume 117,674 Change -0.21%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Downgrade Barclays
Equal Weight → Underweight
$83
Mar-06-24 Initiated Barclays
Equal Weight
$88
Feb-05-24 Resumed William Blair
Outperform
Dec-12-23 Initiated TD Cowen
Outperform
$105
Jun-29-22 Initiated Stifel
Buy
$101
Apr-13-22 Initiated BofA Securities
Buy
$110
Oct-22-19 Resumed Stephens
Overweight
Jun-27-19 Initiated BMO Capital Markets
Market Perform
Feb-04-19 Upgrade Robert W. Baird
Neutral → Outperform
Oct-08-18 Initiated RBC Capital Mkts
Outperform
$81
Aug-21-18 Initiated Jefferies
Buy
$75
Aug-20-18 Initiated Raymond James
Outperform
$75
Sep-30-14 Upgrade Oppenheimer
Perform → Outperform
$24
Jul-16-13 Downgrade Robert W. Baird
Outperform → Neutral
$14 → $20
Apr-04-13 Downgrade Oppenheimer
Outperform → Perform
$12 → $13
Dec-07-09 Initiated Robert W. Baird
Outperform
$13
Dec-07-09 Initiated Oppenheimer
Outperform
$12
Show Previous Ratings
May-02-24 09:40AM
Apr-23-24 09:18AM
08:00AM
Apr-22-24 11:00AM
Apr-13-24 12:18PM
09:00AM
Loading…
Apr-09-24 09:00AM
Mar-05-24 11:00AM
Mar-04-24 09:15AM
Mar-01-24 08:30AM
Feb-29-24 12:00PM
Feb-27-24 11:00AM
Feb-26-24 06:30PM
04:54PM
(Associated Press Finance)
04:53PM
04:05PM
09:15AM
Loading…
Feb-21-24 09:15AM
Feb-12-24 11:00AM
Nov-22-23 09:55AM
Nov-17-23 05:05AM
Nov-06-23 09:55AM
Nov-01-23 12:37PM
11:00AM
Oct-30-23 05:50PM
05:43PM
04:50PM
(Associated Press Finance)
04:05PM
Oct-23-23 10:15AM
Oct-19-23 11:40AM
Oct-17-23 06:21AM
Oct-16-23 12:00PM
08:58AM
Loading…
08:58AM
Oct-10-23 09:40AM
Oct-03-23 11:40AM
Sep-25-23 03:21AM
Sep-24-23 10:30AM
Aug-02-23 04:05PM
Aug-01-23 08:00AM
Jul-31-23 06:25PM
05:12PM
04:05PM
Jul-29-23 11:30AM
Jul-24-23 10:00AM
Jul-23-23 09:03AM
Jul-20-23 12:10PM
Jul-17-23 01:00PM
Jul-03-23 01:01PM
Jun-29-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-09-23 01:39PM
Jun-08-23 12:44PM
Jun-07-23 01:53PM
12:52PM
Jun-06-23 10:20AM
Jun-05-23 02:12PM
11:45AM
11:40AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:04PM
May-29-23 09:55AM
May-26-23 10:55AM
May-25-23 02:30PM
09:35AM
May-24-23 01:42PM
11:00AM
May-23-23 11:23AM
11:01AM
May-22-23 11:13AM
10:48AM
May-19-23 11:39AM
10:48AM
May-18-23 01:12PM
01:09PM
11:40AM
10:50AM
May-17-23 02:15PM
May-11-23 09:40AM
May-09-23 11:00AM
09:35AM
May-02-23 11:16PM
(Thomson Reuters StreetEvents)
11:00AM
May-01-23 05:45PM
04:05PM
02:37PM
11:40AM
08:00AM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
09:40AM
07:38AM
Apr-24-23 10:00AM
Apr-17-23 11:00AM
Apr-14-23 11:40AM
Apr-10-23 09:40AM
Mar-29-23 08:00AM
Mar-24-23 09:40AM
07:07AM
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stevenson Roberton James EVP & Chief HR Officer Apr 01 '24 Sale 103.93 109 11,328 10,434 Apr 02 04:05 PM RAINES MONICA EVP/CCO and Quality Officer Mar 04 '24 Sale 93.86 235 22,057 11,986 Mar 05 04:09 PM ALLISON R DIRK CEO and Chairman Feb 26 '24 Sale 85.95 8,021 689,405 79,397 Feb 27 04:10 PM BICKHAM W BRADLEY President and COO Feb 26 '24 Sale 85.95 5,212 447,971 48,000 Feb 27 04:10 PM POFF BRIAN EVP/Chief Financial Officer Feb 26 '24 Sale 85.95 4,814 413,763 31,544 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Feb 26 '24 Sale 85.94 1,763 151,512 40,754 Feb 27 04:10 PM GAFFNEY SEAN EVP/Chief Legal Officer Feb 26 '24 Sale 85.95 1,639 140,872 18,002 Feb 27 04:10 PM TUCKER DAVID W. EVP/Chief Strategy Officer Feb 26 '24 Sale 85.96 1,347 115,788 10,497 Feb 27 04:10 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 26 '24 Sale 85.95 1,176 101,077 9,132 Feb 27 04:10 PM Stevenson Roberton James EVP & Chief HR Officer Feb 26 '24 Sale 85.95 714 61,368 10,543 Feb 27 04:10 PM RAINES MONICA EVP/CCO and Quality Officer Feb 26 '24 Sale 85.96 538 46,246 12,221 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Option Exercise 23.10 9,690 223,839 46,550 Nov 16 04:39 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Sale 85.00 9,690 823,650 36,860 Nov 16 04:39 PM TUCKER DAVID W. EVP / Chief Strategy Officer Nov 08 '23 Sale 83.45 248 20,696 6,973 Nov 09 05:13 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Nov 08 '23 Sale 83.45 235 19,611 5,987 Nov 09 05:14 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Option Exercise 23.10 3,008 69,485 39,868 Nov 09 05:13 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Sale 85.00 3,008 255,680 36,860 Nov 09 05:13 PM BICKHAM W BRADLEY President and COO Aug 07 '23 Sale 93.85 5,000 469,250 38,285 Aug 08 05:01 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 07 '23 Sale 94.23 1,636 154,160 7,221 Aug 08 05:01 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 07 '23 Sale 93.96 750 70,470 6,222 Aug 08 05:02 PM POFF BRIAN EVP/Chief Financial Officer Aug 04 '23 Sale 93.55 4,140 387,316 22,217 Aug 04 05:30 PM ALLISON R DIRK CEO and Chairman Aug 03 '23 Sale 94.39 24,922 2,352,473 52,850 Aug 04 05:29 PM Stevenson Roberton James EVP & Chief HR Officer Jun 15 '23 Sale 92.61 217 20,096 7,329 Jun 20 05:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
